Clinical Pathways
The majority of large health systems and oncology provider groups use clinical pathways in their efforts to standardize cancer treatment, improve patient outcomes, and control costs. According to a recent survey, 70% of healthcare decision-makers use clinical pathways at their organization,¹ and pathway adherence rates of ~80% are reported by one of our panelists.
In this 4-episode video series, Dr Evan Slater and Dr Sophia Humphreys share their perspectives on implementing clinical pathways and measuring the impact.
The future of clinical pathway development and implementation may be impacted by technologies such as artificial intelligence.